OKYO Pharma Statistics Share Statistics OKYO Pharma has 37.61M
shares outstanding. The number of shares has increased by 10.99%
in one year.
Shares Outstanding 37.61M Shares Change (YoY) 10.99% Shares Change (QoQ) 0.5% Owned by Institutions (%) 0.13% Shares Floating 25.08M Failed to Deliver (FTD) Shares 305 FTD / Avg. Volume 0.22%
Short Selling Information The latest short interest is 21.3K, so 0.06% of the outstanding
shares have been sold short.
Short Interest 21.3K Short % of Shares Out 0.06% Short % of Float 0.08% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -10.66 and the forward
PE ratio is -14.14.
OKYO Pharma's PEG ratio is
0.
PE Ratio -10.66 Forward PE -14.14 PS Ratio 0 Forward PS n/a PB Ratio -9.04 P/FCF Ratio -27.67 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OKYO Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.4,
with a Debt / Equity ratio of 0.
Current Ratio 0.4 Quick Ratio 0.4 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -8.14
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.57M Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.26M Effective Tax Rate 40.95%
Stock Price Statistics The stock price has increased by 91.59% in the
last 52 weeks. The beta is -4.46, so OKYO Pharma's
price volatility has been lower than the market average.
Beta -4.46 52-Week Price Change 91.59% 50-Day Moving Average 2.42 200-Day Moving Average 1.79 Relative Strength Index (RSI) 42.45 Average Volume (20 Days) 136,966
Income Statement
Revenue n/a Gross Profit -2.56K Operating Income -7.19M Net Income -4.71M EBITDA -7.08M EBIT -7.09M Earnings Per Share (EPS) -0.12
Full Income Statement Balance Sheet The company has 1.56M in cash and 0 in
debt, giving a net cash position of 1.56M.
Cash & Cash Equivalents 1.56M Total Debt n/a Net Cash n/a Retained Earnings -143.02M Total Assets 3.68M Working Capital -5.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.81M
and capital expenditures -1.21K, giving a free cash flow of -1.81M.
Operating Cash Flow -1.81M Capital Expenditures -1.21K Free Cash Flow -1.81M FCF Per Share -0.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
